UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.

15/10/2022 15/10/2022

Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis

This review indicates an association between psychedelic therapy and significant reduction of depressive symptoms at several time points.

11/06/2022 11/06/2022

Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder

11/06/2022 11/06/2022

Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions

We conclude that combination psychedelic treatment and psychotherapy facilitate more enduring and profound antidepressant effects than produced by ketamine or psilocybin alone.

30/05/2022 30/05/2022

Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation

05/04/2022 05/04/2022

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

19/02/2022 19/02/2022

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

These findings demonstrate that the substantial antidepressant effects of psilocybin-assisted therapy may be durable at least through 12 months following acute intervention in some patients.